Clinical Trial Update: A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A [Phase 3]

View source ↗

Summary

A multinational Phase 3 open-label trial assessed safety, efficacy, and pharmacokinetics of NNC 0129-0000-1003 in previously treated paediatric patients with se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• NNC 0129-0000-1003

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2019-10-30